My best guess is that they want to execute them as fast as possible, and need quantity to do that (up to 150 million shares worth of warrants - dependant on executed price).

Easier to dump more shares for a lower price, and since the worst case scenario for Anson is that they pay 80% of what the shares are worth to sit on the ask until they are sold, they are still making a good profit the whole way through.

It's not good for the typical shareholder, but what's done is done - Generex needed the cash flow at the time. They didn't have these licensing deals with upfront payments coming in during the summer.